Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.

Jason K SicklickShumei KatoRyosuke OkamuraHitendra PatelMina NikanjamPaul T FantaMichael E HahnPradip DeCasey WilliamsJessica GuidoBenjamin M SolomonRana R McKayAmy KrieSarah G BolesJeffrey S RossJ Jack LeeBrian Leyland-JonesScott M LippmanRazelle Kurzrock

Published in: Genome medicine (2021)

I-PREDICT ( NCT02534675 ) was registered on August 25, 2015.

Keyphrases

single cell
single molecule